Depixol Low Volume is a formulation of flupentixol, a typical antipsychotic medication primarily used in the treatment and management of schizophrenia and other disorders characterized by disturbed thoughts and emotions. It belongs to the class of drugs known as thioxanthenes and works by blocking dopamine receptors in the brain, which helps to normalize the imbalance of neurotransmitters that contributes to the symptoms of psychosis. The "Low Volume" designation typically refers to a concentrated form of the medication that allows for administration of the required dose in a smaller volume of liquid, making it easier and more comfortable for patients to take, especially in a long-acting injectable form for those who have difficulty with daily oral medication adherence. This medication is used under the guidance of healthcare professionals to ensure its efficacy and monitor any potential side effects.